SIMABS
Agoralaan, Abis Abis /
3590 Diepenbeek
BE
SIMABS
Foundation date
22/08/2019
Sector
#Biotechnology / R&D ServicesSubsector
- #Therapeutics - Biosimilars
- #Therapeutics - Nucleic acid drugs
- #Therapeutics - Proteins
- #R&D Services - Cell culture
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - Synthesis services
Therapeutic areas
SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
2304 '24
BioTrinity 2024
Event by: OBN -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB
Latest news
More news-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
-
Innovating today, creating tomorrow: the VIB Bio-Incubator
Thursday April 18th 2024
Read more
-
BioLizard Appoints Matthew Hall as Director of Business Development
Thursday April 18th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator